Endothelial nitric oxide synthase VNTR (intron 4 a/b) polymorphism association with type 2 diabetes and its chronic complications

Diabetes Research and Clinical Practice

Volumn 91, Issue 3, 2011, Pages 348-352

  Mehrab Mohseni, Mahdieh ^a   Tabatabaei Malazy, Ozra ^b   Hasani Ranjbar, Shirin ^b   Amiri, Parvin ^b   Kouroshnia, Arghavan ^b   Bazzaz, Javad Tavakkoly ^c   Farahani Shrhabi, Maryam ^b   Larijani, Bagher ^b   Amoli, Mahsa M ^b  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

ENOS; Polymorphism; T2DM

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DIABETIC ANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC CORRELATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INTRON; IRAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; POLYMERASE CHAIN REACTION; RISK ASSESSMENT; VARIABLE NUMBER OF TANDEM REPEAT;

ADULT; AGED; CASE-CONTROL STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INTRONS; IRAN; MALE; MIDDLE AGED; MINISATELLITE REPEATS; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, GENETIC;

EID: 79952363982     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2010.12.030     Document Type: Article

References (29)

1. Tso A.W., Tan K.C., Wat N.M., Janus E.D., Lam T.H., Lam S.L.K. Endothelial nitric oxide synthase G894T (Glu298Asp) polymorphism was predictive of glycemic status in a 5-year prospective study of Chinese subjects with impaired glucose tolerance. Metabolism 2006, 55(September (9)):1155-1158.
2. Pieper G.M. Enhanced, unaltered and impaired nitric oxide-mediated endothelium-dependent relaxation in experimental diabetes mellitus: importance of disease duration. Diabetologia 1999, 42(February (2)):204-213.
3. Monti L.D., Barlassina C., Citterio L., Galluccio E., Berzuini C., Setola E., et al. Endothelial nitric oxide synthase polymorphisms are associated with type 2 diabetes and the insulin resistance syndrome. Diabetes 2003, 52(May (5)):1270-1275.
4. Honing M.L., Morrison P.J., Banga J.D., Stroes E.S., Rabelink T.J. Nitric oxide availability in diabetes mellitus. Diabetes Metab Rev 1998, 14:241-249.
5. Ceriello A., dello R.P., Amstad P., Cerutti P. High glucose induces antioxidant enzymes in human endothelial cells in culture. Evidence linking hyperglycemia and oxidative stress. Diabetes 1996, 45:471-477.
6. Cosentino F., Hishikawa K., Katusic Z.S., Luscher T.F. High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation 1997, 96:25-28.
7. Spinas GA, Laffranchi R, Francoys I, David I, Richter C, Reinecke M. The early phase of glucose-stimulated insulin secretion requires nitric oxide. Diabetologia 1998,41:292-9.
8. Laffranchi R., Gogvadze V., Richter C., Spinas G.A. Nitric oxide (nitrogen monoxide, NO) stimulates insulin secretion by inducing calcium release from mitochondria. Biochem Biophys Res Commun 1995, 217:584-591.
9. Choi K.C., Lee S.C., Kim S.W., Kim N.H., Lee J.U., Kang Y.J. Role of nitric oxide in the pathogenesis of diabetic nephropathy in streptozotocin-induced diabetic rats. Korean J Intern Med 1999, 14:32-41.
10. Tsurumi Y., Murohara T., Krasinski K., Chen D., Witzenbichler B., Kearney M., et al. Reciprocal relation between VEGF and NO in the regulation of endothelial integrity. Nat Med 1997, 3:879-886.
11. Moncada S. Nitric oxide in the vasculature: physiology and pathophysiology. Ann NY Acad Sci 1997, 811:60-67.
12. Marsden P.A., Heng H.H., Scherer S.W., Stewart R.J., Hall A.V., Shi X.M., et al. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem 1993, 268:17478-17488.
13. Nadaud S., Bonnardeaux A., Lathrop M., Soubrier F. Gene structure, polymorphism and mapping of the human endothelial nitric oxide synthase gene. Biochem Biophys Res Commun 1994, 198:1027-1033.
14. Wang X.L., Wang J. Endothelial nitric oxide synthase gene sequence variations and vascular disease. Mol Genet Metab 2000, 70:241-251.
15. Ezzidi I., Mtiraoui N., Mohamed M.B., Mahjoub T., Kacem M., Almawi W.Y. Association of endothelial nitric oxide synthase Glu298Asp, 4b/a, and -786T>C gene variants with diabetic nephropathy. J Diabetes Complications 2008, 22(September-October (5)):331-338.
16. Ezzidi I., Mtiraoui N., Mohamed M.B., Mahjoub T., Kacem M., Almawi W.Y. Endothelial nitric oxide synthase Glu298Asp, 4b/a, and T-786C polymorphisms in type 2 diabetic retinopathy. Clin Endocrinol (Oxf) 2008, 68(April (4)):542-546.
17. Farjadian S.H., Ota M., Inoko H., Ghaderi A. The genetic relationship among Iranian ethnic groups: an anthropological view based on HLA class II gene polymorphism. Mol Biol Rep 2009, 36:1943-1950.
18. Genuth S., Alberti K.G., Bennett P., Buse J., Defronzo R., Kahn R., et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003, 26(11):3160-3167.
19. DCCT Research Group Factors in development of diabetic neuropathy. Baseline analysis of neuropathy in feasibility phase of Diabetes Control and Complications Trial (DCCT). The DCCT Research Group. Diabetes 1988, 37(4):476-481.
20. Amoli M.M., Garcia-Porrua C., Llorca J., Ollier W.E., Gonzalez-Gay M.A. Endothelial nitric oxide synthase haplotype associations in biopsy-proven giant cell arteritis. J Rheumatol 2003, 30(September (9)):2019-2022.
21. Baron A.D., Steinberg H., Brechtel G., Johnson A. Skeletal muscle blood flow independently modulates insulin-mediated glucose uptake. Am J Physiol 1994, 266:E248-E253.
22. Miyamoto Y., Saito Y., Kajiyama N., Yoshimura M., Shimasaki Y., Nakayama M., et al. Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension 1998, 32:3-8.
23. Hyndman M.E., Parsons H.G., Verma S., Bridge P.J., Edworthy S., Jones C., et al. The T-786 C mutation in endothelial nitric oxide synthase is associated with hypertension. Hypertension 2002, 39:919-922.
24. González-Sánchez J.L., Martínez-Larrad M.T., Sáez M.E., Zabena C., Martínez-Calatrava M.J., Serrano-Ríos M. Endothelial nitric oxide synthase haplotypes are associated with features of metabolic syndrome. Clin Chem 2007, 53(1):91-97.
25. Bazzaz J.T., Amoli M.M., Pravica V., Chandrasecaran R., Boulton A.J., Larijani B., et al. eNOS gene polymorphism association with retinopathy in type 1 diabetes. Ophthalmic Genet 2010, 31(3):103-107. Sep.
26. Rittig K., Holder K., Stock J., Tschritter O., Peter A., Stefan N., et al. Endothelial NO-synthase intron 4 polymorphism is associated with disturbed in vivo nitric oxide production in individuals prone to type 2 diabetes. Horm Metab Res 2008, 40(January (1)):13-17.
27. Salimi S., Firoozrai M., Nourmohammadi I., Shabani M., Mohebbi A. Endothelial nitric oxide synthase gene intron 4 VNTR polymorphism in patients with coronary artery disease in Iran. Indian J Med Res 2006, 124:683-688.
28. de Syllos R.W., Sandrim V.C., Lisboa H.R., Tres G.S., Tanus-Santos J.E. Endothelial nitric oxide synthase genotype and haplotype are not associated with diabetic retinopathy in type 2diabetes patients. Nitric Oxide 2006, 15:417-422.
29. Suganthalakshmi B., Anand R., Kim R., Mahalakshmi R., Karthikprakash S., Namperumalsamy P., et al. Association of VEGF and eNOS gene polymorphisms in type 2 diabetic retinopathy. Mol Vis 2006, 12:336-341.